Clinical Trial: a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07502651) titled 'a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture' on March 24.

Brief Summary: COMPARISON OF THE EFFICACY OF INTRANASAL MIDAZOLAM AND DEXMEDETOMIDINE AS A SEDATIVE AGENT IN SURGICAL MANAGEMENT OF ISOLATED MANDIBLE FRACTURE- conducted on 32 subject to assess depth of sedation by using OAA/S and assess effect on bp and heart rate

Study Start Date: May 25, 2025

Study Type: INTERVENTIONAL

Condition: Sedation

Intervention: DRUG: Midazolam (Intranasal)

Midazolam administered intranasally at a dose appropriate for conscious sedati...